+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Nucleic Acid Kits
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Transfected Stable Cell Lines

CD19/CD20 Double Knockout Raji/Luciferase Cell Line

  • BSL

    1

  • 40
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Home | Transfected Stable Cell Lines | CD19/CD20 Double Knockout Raji/Luciferase Cell Line
Species

Human
Cat.No

ABC-RC055Y
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.
Product Category Transfected Stable Cell Lines
Size/Quantity

1 vial
Cell Type

Lymphoblast-like
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Burkitt’s Lymphoma
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Reporter Stable Cell Lines
Host Cell

Raji
Gene Info

CD19 / CD20 / Luciferase

Description

CD19/CD20 Double Knockout Raji/Luciferase Cell Line is a genetically engineered B-lymphocyte model derived from Raji cells, featuring stable luciferase(Luc) reporter expression and complete knockout of both CD19 and CD20 (MS4A1) surface markers. This cell line maintains characteristic Raji cell morphology and proliferation kinetics while providing sensitive bioluminescence for in vivo tracking. The dual knockout of key B-cell antigens creates a valuable model for studying resistance mechanisms to CD19/CD20-targeted immunotherapies (including CAR-T and monoclonal antibodies) and developing alternative treatment strategies. With stable luciferase expression maintained at low passages (<P20), this line enables quantitative tumor monitoring in xenograft studies while serving as a platform for investigating antigen escape in B-cell malignancies. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, mycoplasma, Fungi, Yeast and Bacteria.

AcceGen Frozen Cells & Cell Lines 1 vial
View Product Image

Application

  • FOR RESEARCH USE ONLY

  • The CD19/CD20 Double Knockout Raji/Luciferase Cell Line is an engineered B-cell lymphoma model featuring complete genetic disruption of both CD19 and CD20 markers alongside stable luciferase reporter integration. This triple-modified system enables quantitative bioluminescence tracking of tumor progression while serving as a critical tool for studying resistance mechanisms to dual-antigen targeted immunotherapies (e.g., CAR-T, bispecific antibodies). Particularly valuable for investigating alternative B-cell signaling pathways and developing next-generation lymphoma treatments, the cell line maintains consistent phenotypic and functional characteristics when cultured in RPMI-1640 with 10% FBS and appropriate antibiotics.

  • Online Inquiry
  • Product Reviews

Inquiring CD19/CD20 Double Knockout Raji/Luciferase Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button